ID: ALA4075814

Max Phase: Preclinical

Molecular Formula: C17H22N2

Molecular Weight: 254.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc2c3c([nH]c2c1)CC(NC1CCCC1)CC3

Standard InChI:  InChI=1S/C17H22N2/c1-2-6-12(5-1)18-13-9-10-15-14-7-3-4-8-16(14)19-17(15)11-13/h3-4,7-8,12-13,18-19H,1-2,5-6,9-11H2

Standard InChI Key:  JNWSPWONWPCWLI-UHFFFAOYSA-N

Associated Targets(Human)

Retinoblastoma-associated protein 82 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 254.38Molecular Weight (Monoisotopic): 254.1783AlogP: 3.56#Rotatable Bonds: 2
Polar Surface Area: 27.82Molecular Species: BASEHBA: 1HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.53CX LogP: 3.51CX LogD: 0.63
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.84Np Likeness Score: -0.38

References

1. Kulkarni MR, Mane MS, Ghosh U, Sharma R, Lad NP, Srivastava A, Kulkarni-Almeida A, Kharkar PS, Khedkar VM, Pandit SS..  (2017)  Discovery of tetrahydrocarbazoles as dual pERK and pRb inhibitors.,  134  [PMID:28431342] [10.1016/j.ejmech.2017.02.062]

Source